Key Takeaways
Key players operating in the downstream processing market are Merck KGaA,
Thermo Fisher Scientific Inc., GE Healthcare, Sartorius Stedim Biotech S.A.,
Repligen Corporation, Pall Corporation, M Company, Eppendorf AG, Agilent
Technologies, Inc., Waters Corporation, Shimadzu Corporation, Bio-Rad
Laboratories, Inc., Avantor Performance Materials, LLC, Tosoh Corporation,
Column Technology Inc., Purolite, W.R. Grace & Co., Asahi Kasei
Corporation, Novasep Holding S.A.S, and Boehringer Ingelheim. Merck KGaA
dominates the downstream processing market with highest market share owing to
its comprehensive downstream processing technology portfolio.
The increasing demand for biological drugs for treatment of chronic diseases
and rising government emphasis on vaccine manufacturing is expected to surge
the demand for downstream processing. According to a report, global COVID-19
vaccine manufacturing capacity is expected to reach 24 billion doses by 2023.
This will drive significant growth in
Downstream
Processing Market Demand.
Technological advancements in downstream processing equipment such as use of
single-use technologies, improved column chromatography resins, acoustic
separators and automated analytical systems are leading to enhanced efficiency,
cost-effectiveness and higher throughput. This will augment the downstream
processing market size during the forecast period.
Market Trends
Some key trends in the downstream processing market include:
- Growing preference for single-use technologies: Single-use technologies
facilitate on-demand manufacturing, lower equipment requirements and lower risk
of cross-contamination. Their adoption is increasing rapidly.
- Automation of operations: Technologies enabling automated liquid handling,
chromatography control and automated validation are being adopted to enhance
throughput, reproducibility and operational consistency.
- Continuous manufacturing: Continuous manufacturing is gaining prominence as
it provides higher yields than batch manufacturing. Continuous chromatography
and continuous tubular mixer settlers are key technologies.
Market Opportunities
The key opportunities in the downstream processing market are:
- Cell and gene therapy manufacturing: Growing cell and gene therapy clinical
pipeline will drive significant demand for improved purification technologies
in downstream processing.
- Biopharmaceuticals for emerging markets: As biopharmaceutical access
increases in emerging Asian and Latin American countries, local manufacturing
capacities are being enhanced through partnerships. This offers significant
opportunities.
Impact of COVID-19 on Downstream Processing Market
The COVID-19 pandemic has significantly impacted the growth of the downstream
processing market. Due to lockdowns imposed across various countries,
disruptions were caused across biotech and pharmaceutical supply chains. This
led to delays in new product launches and reduced capacity utilization of
manufacturing facilities. Additionally, travel restrictions made it difficult
for companies to transport raw materials and finished products. The lockdowns
also resulted in temporary shutdowns of several R&D and manufacturing
facilities, negatively impacting the demand for downstream processing products
in 2020.
However, with vaccination drives picking up pace globally, production and
supply chain activities are recovering fast. There is renewed focus on
developing vaccines and therapeutics for COVID-19, boosting the demand for
downstream processing. Companies are ramping up their production capacities to
meet the surge in demand. The pandemic has also highlighted the need to enhance
preparedness for health emergencies. This is encouraging investments in
building and expanding manufacturing infrastructure, which will drive growth
opportunities for downstream processing vendors. Several countries are
providing funding and tax incentives to boost domestic bioproduction, which
will further aid the market recovery. The long-term impact of COVID-19 is
expected to be positive as it has catalyzed investments in healthcare
infrastructure and drug development globally.
North America holds the largest share of the downstream processing market in
terms of value. This is attributed to presence of several global players, rising
biopharmaceutical R&D expenditure, and rapid adoption of advanced
technologies. Europe is another major region concentrated with downstream
processing companies due to increasing focus on healthcare. Asia Pacific is
poised to be the fastest growing regional market, driven by rising biologics
production in countries like China, India, and South Korea. Government support
in the form of investments and favorable business policies will continue
fueling growth opportunities across APAC.
Comments
Post a Comment